Literature DB >> 16822965

Paraoxonase gene polymorphisms and sporadic ALS.

A Slowik1, B Tomik, P P Wolkow, D Partyka, W Turaj, M T Malecki, J Pera, T Dziedzic, A Szczudlik, D A Figlewicz.   

Abstract

BACKGROUND: The human paraoxonase (PON) gene family consists of three members, PON1, PON2, and PON3, located adjacent to each other on chromosome 7. PON catalytic activity may be influenced by frequent amino acid variants. Chronic exposure to certain chemicals or to environmental factors causing enhanced lipid peroxidation metabolized by paraoxonases may be a risk factor for sporadic ALS (sALS).
OBJECTIVE: The aim of this study was to examine the association between PON1 Q192R, PON1 L55M, and PON2 C311S functional polymorphisms and the risk of sALS in a Polish population.
METHODS: The authors included 185 patients with a definite or probable diagnosis of sALS (El Escorial Criteria) and 437 healthy controls of similar age and gender. The paraoxonase polymorphisms were studied by PCR and restriction enzyme digestion.
RESULTS: Using logistic regression analyses, the C allele of the C311S polymorphism was associated with sALS in dominant and additive models, whereas the R allele of the Q192R polymorphism was associated with sALS in recessive, additive, and dominant models. The authors compared the distribution of haplotypes between cases and controls. The R-C haplotype was overrepresented among cases (odds ratio 3.44, 95% CI: 1.55 to 7.62, p = 0.002).
CONCLUSIONS: Frequent amino acid variants in the paraoxonase 1 and paraoxonase 2 genes are associated with sporadic ALS in a Polish population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16822965     DOI: 10.1212/01.wnl.0000219565.32247.11

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

1.  The paraoxonase disruption hypothesis in sporadic ALS steamrolled.

Authors:  Philipp G Sand
Journal:  Neurol Sci       Date:  2016-02-17       Impact factor: 3.307

2.  The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis.

Authors:  Frank O Johnson; William D Atchison
Journal:  Neurotoxicology       Date:  2009-07-24       Impact factor: 4.294

Review 3.  Clinical genetics of amyotrophic lateral sclerosis: what do we really know?

Authors:  Peter M Andersen; Ammar Al-Chalabi
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

Review 4.  Genetics of Amyotrophic Lateral Sclerosis.

Authors:  Mehdi Ghasemi; Robert H Brown
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

5.  Phenotypic heterogeneity in a SOD1 G93D Italian ALS family: an example of human model to study a complex disease.

Authors:  Silvana Penco; Christian Lunetta; Lorena Mosca; Eleonora Maestri; Francesca Avemaria; Claudia Tarlarini; Maria Cristina Patrosso; Alessandro Marocchi; Massimo Corbo
Journal:  J Mol Neurosci       Date:  2010-12-01       Impact factor: 3.444

6.  Paraoxonase gene mutations in amyotrophic lateral sclerosis.

Authors:  Nicola Ticozzi; Ashley Lyn LeClerc; Pamela J Keagle; Jonathan D Glass; Anne-Marie Wills; Marka van Blitterswijk; Daryl A Bosco; Ildefonso Rodriguez-Leyva; Cinzia Gellera; Antonia Ratti; Franco Taroni; Diane McKenna-Yasek; Peter C Sapp; Vincenzo Silani; Clement E Furlong; Robert H Brown; John E Landers
Journal:  Ann Neurol       Date:  2010-07       Impact factor: 10.422

7.  Regulation of FMO and PON detoxication systems in ALS human tissues.

Authors:  Stella Gagliardi; Kenneth Abel; Marika Bianchi; Pamela Milani; Stefano Bernuzzi; Manuel Corato; Mauro Ceroni; John R Cashman; Cristina Cereda
Journal:  Neurotox Res       Date:  2012-10-17       Impact factor: 3.911

8.  Genes and Environmental Exposures in Veterans with Amyotrophic Lateral Sclerosis: the GENEVA study. Rationale, study design and demographic characteristics.

Authors:  Silke Schmidt; Kelli D Allen; Valerie T Loiacono; Barbara Norman; Catherine L Stanwyck; Kristina M Nord; Christina D Williams; Edward J Kasarskis; Freya Kamel; Valerie McGuire; Lorene M Nelson; Eugene Z Oddone
Journal:  Neuroepidemiology       Date:  2008-04-18       Impact factor: 3.282

9.  Genome-wide association reveals three SNPs associated with sporadic amyotrophic lateral sclerosis through a two-locus analysis.

Authors:  Qiuying Sha; Zhaogong Zhang; Jennifer C Schymick; Bryan J Traynor; Shuanglin Zhang
Journal:  BMC Med Genet       Date:  2009-09-09       Impact factor: 2.103

10.  A common haplotype within the PON1 promoter region is associated with sporadic ALS.

Authors:  John E Landers; Lijia Shi; Ting-Jan Cho; Jonathan D Glass; Christopher E Shaw; P Nigel Leigh; Frank Diekstra; Meraida Polak; Ildefonso Rodriguez-Leyva; Stephan Niemann; Bryan J Traynor; Diane McKenna-Yasek; Peter C Sapp; Ammar Al-Chalabi; Anne-Marie A Wills; Robert H Brown
Journal:  Amyotroph Lateral Scler       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.